メディカルライティングにおけるAI市場規模、成長と動向分析レポート 2025-2030年

AI In Medical Writing Market Growth & Trends

The global AI in medical writing market size is anticipated to reach USD 1,760.02 million by 2030, registering a CAGR of 12.52% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factor driving the market expansion is the growing acceptance of machine learning, such as Artificial Intelligence(AI), in the healthcare industry. Moreover, the rising demand for reducing healthcare expenditures and increasing R&D investments by pharmaceutical companies to reduce expenses are other factors that are propelling market growth. The COVID-19 pandemic had affected the market moderately. The pandemic caused a pause in research and development activities as well as clinical trials.

Grand View Research, Inc.の新しいレポートによると、世界のメディカルライティングにおけるAI市場規模は、2030年までに17億6,002万米ドルに達し、2025年から2030年にかけて12.52%のCAGRを記録すると予想されています。市場拡大を推進する主な要因は、ヘルスケア業界で人工知能(AI)などの機械学習の受け入れが拡大していることです。さらに、医療費削減の需要の高まりと、経費削減を目的とした製薬会社による研究開発投資の増加も、市場の成長を推進する他の要因です。COVID-19パンデミックは市場に中程度の影響を及ぼしました。パンデミックにより、研究開発活動と臨床試験が一時停止しました。

Moreover, budgetary limitations led many pharmaceutical companies to reduce their investments. The initial stages of the pandemic also resulted in a decrease in submissions to healthcare journals, negatively impacting market growth. However, the significance of collaborative efforts between companies, research groups, and government bodies in the development of innovative therapies was demonstrated during the COVID-19 pandemic. Consequently, medical device, biotechnology, and life science companies have intentions to boost their investment in medical writers. Thus, increasing the demand for AI in the healthcare industry during the COVID-19 pandemic.

さらに、予算の制約により、多くの製薬会社は投資を削減しました。パンデミックの初期段階では、ヘルスケアジャーナルへの投稿も減少し、市場の成長に悪影響を及ぼしました。しかし、革新的な治療法の開発における企業、研究グループ、政府機関間の協力の重要性は、COVID-19パンデミック中に実証されました。その結果、医療機器、バイオテクノロジー、ライフサイエンス企業は、メディカルライターへの投資を増やす意向を持っています。そのため、COVID-19パンデミック中にヘルスケア業界でAIの需要が高まっています。

AI In Medical Writing Market Report Scope

AI In Medical Writing Market Report Highlights

• Based on type, the typewriting segment dominated the market with a share of 32.89% of the overall revenue in 2024 due to the necessity of submitting regulatory documents to the authorities. Thus, boosting the demand for AI in medical writing in this segment

• Based on end-use, the pharmaceutical segment dominated the market with a revenue share of 33.33% in 2024.

• The high share was attributed to the heavy investments in R&D activities to develop new drugs and treatments, which augmented the demand for AI in medical writing in this end-use segment

• In 2024, North America dominated the market with a revenue share of 30.12% owing to the continuous technological advancements, increasing healthcare infrastructure, and a high number of drug trials & their approvals

Table of Contents

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Type

1.1.2. End Use

1.1.3. Regional scope

1.1.4. Estimates and forecast timeline.

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database.

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.2. Approach 1: Commodity flow approach

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Type outlook

2.2.2. End use outlook

2.2.3. Regional outlook

2.3. Competitive Insights

Chapter 3. AI in Medical Writing Market Variables, Trends & Scope

3.1. Market Dynamics

3.1.1. Market driver analysis

3.1.2. Market restraint analysis

3.1.3. Market Opportunities

3.2. AI in Medical Writing Market Analysis Tools

3.2.1. Industry Analysis – Porter’s

3.2.1.1. Supplier power

3.2.1.2. Buyer power

3.2.1.3. Substitution threat

3.2.1.4. Threat of new entrant

3.2.1.5. Competitive rivalry

3.2.2. PESTEL Analysis

3.2.2.1. Political landscape

3.2.2.2. Economic landscape

3.2.2.3. Social landscape

3.2.2.4. Technological landscape

3.2.2.5. Environmental landscape

3.2.2.6. Legal landscape

3.2.3. COVID-19 Impact Analysis

3.2.4. Case Studies

Chapter 4. AI in Medical Writing Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2024 & 2030

4.2. Segment Dashboard

4.3. Global AI in Medical Writing Market by Product Type Outlook

4.4. Clinical Writing

4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

4.5. Scientific Writing

4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

4.6. Type Writing

4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

4.7. Others

4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. AI in Medical Writing Market: End Use Estimates & Trend Analysis

5.1. End Use Market Share, 2024 & 2030

5.2. Segment Dashboard

5.3. Global AI in Medical Writing Market by End Use Outlook

5.4. Medical Devices

5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.5. Pharmaceutical

5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.6. Biotechnology

5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

5.7. Others

5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. AI in Medical Writing Market: Regional Estimates & Trend Analysis, By Product, By Type, By End Use

6.1. Regional Market Share Analysis, 2024 & 2030

6.2. Regional Market Dashboard

6.3. Global Regional Market Snapshot

6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:

6.5. North America

6.5.1. U.S.

6.5.1.1. Key country dynamics

6.5.1.2. Regulatory framework/ reimbursement structure

6.5.1.3. Competitive scenario

6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)

6.5.2. Canada

6.5.2.1. Key country dynamics

6.5.2.2. Regulatory framework/ reimbursement structure

6.5.2.3. Competitive scenario

6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

6.5.3. Mexico

6.5.3.1. Key country dynamics

6.5.3.2. Regulatory framework/ reimbursement structure

6.5.3.3. Competitive scenario

6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

6.6. Europe

6.6.1. UK

6.6.1.1. Key country dynamics

6.6.1.2. Regulatory framework/ reimbursement structure

6.6.1.3. Competitive scenario

6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)

6.6.2. Germany

6.6.2.1. Key country dynamics

6.6.2.2. Regulatory framework/ reimbursement structure

6.6.2.3. Competitive scenario

6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)

6.6.3. France

6.6.3.1. Key country dynamics

6.6.3.2. Regulatory framework/ reimbursement structure

6.6.3.3. Competitive scenario

6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)

6.6.4. Italy

6.6.4.1. Key country dynamics

6.6.4.2. Regulatory framework/ reimbursement structure

6.6.4.3. Competitive scenario

6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)

6.6.5. Spain

6.6.5.1. Key country dynamics

6.6.5.2. Regulatory framework/ reimbursement structure

6.6.5.3. Competitive scenario

6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)

6.6.6. Norway

6.6.6.1. Key country dynamics

6.6.6.2. Regulatory framework/ reimbursement structure

6.6.6.3. Competitive scenario

6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)

6.6.7. Sweden

6.6.7.1. Key country dynamics

6.6.7.2. Regulatory framework/ reimbursement structure

6.6.7.3. Competitive scenario

6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)

6.6.8. Denmark

6.6.8.1. Key country dynamics

6.6.8.2. Regulatory framework/ reimbursement structure

6.6.8.3. Competitive scenario

6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

6.7. Asia Pacific

6.7.1. Japan

6.7.1.1. Key country dynamics

6.7.1.2. Regulatory framework/ reimbursement structure

6.7.1.3. Competitive scenario

6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)

6.7.2. China

6.7.2.1. Key country dynamics

6.7.2.2. Regulatory framework/ reimbursement structure

6.7.2.3. Competitive scenario

6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

6.7.3. India

6.7.3.1. Key country dynamics

6.7.3.2. Regulatory framework/ reimbursement structure

6.7.3.3. Competitive scenario

6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)

6.7.4. Australia

6.7.4.1. Key country dynamics

6.7.4.2. Regulatory framework/ reimbursement structure

6.7.4.3. Competitive scenario

6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)

6.7.5. South Korea

6.7.5.1. Key country dynamics

6.7.5.2. Regulatory framework/ reimbursement structure

6.7.5.3. Competitive scenario

6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)

6.7.6. Thailand

6.7.6.1. Key country dynamics

6.7.6.2. Regulatory framework/ reimbursement structure

6.7.6.3. Competitive scenario

6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)

6.8. Latin America

6.8.1. Brazil

6.8.1.1. Key country dynamics

6.8.1.2. Regulatory framework/ reimbursement structure

6.8.1.3. Competitive scenario

6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)

6.8.2. Argentina

6.8.2.1. Key country dynamics

6.8.2.2. Regulatory framework/ reimbursement structure

6.8.2.3. Competitive scenario

6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)

6.9. MEA

6.9.1. South Africa

6.9.1.1. Key country dynamics

6.9.1.2. Regulatory framework/ reimbursement structure

6.9.1.3. Competitive scenario

6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)

6.9.2. Saudi Arabia

6.9.2.1. Key country dynamics

6.9.2.2. Regulatory framework/ reimbursement structure

6.9.2.3. Competitive scenario

6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

6.9.3. UAE

6.9.3.1. Key country dynamics

6.9.3.2. Regulatory framework/ reimbursement structure

6.9.3.3. Competitive scenario

6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

6.9.4. Kuwait

6.9.4.1. Key country dynamics

6.9.4.2. Regulatory framework/ reimbursement structure

6.9.4.3. Competitive scenario

6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants

7.2. Company/Competition Categorization

7.3. Key company market share/position analysis, 2024

7.4. Company Profiles

7.4.1. Parexel International (MA) Corporation.

7.4.1.1. Company overview

7.4.1.2. Financial performance

7.4.1.3. Technology Type benchmarking

7.4.1.4. Strategic initiatives

7.4.2. Trilogy Writing & Consulting GmbH

7.4.2.1. Company overview

7.4.2.2. Financial performance

7.4.2.3. Technology Type benchmarking

7.4.2.4. Strategic initiatives

7.4.3. Freyr

7.4.3.1. Company overview

7.4.3.2. Financial performance

7.4.3.3. Technology Type benchmarking

7.4.3.4. Strategic initiatives

7.4.4. Cactus Communications

7.4.4.1. Company overview

7.4.4.2. Financial performance

7.4.4.3. Technology Type benchmarking

7.4.4.4. Strategic initiatives

7.4.5. GENINVO

7.4.5.1. Company overview

7.4.5.2. Financial performance

7.4.5.3. Technology Type benchmarking

7.4.5.4. Strategic initiatives

7.4.6. IQVIA Inc.

7.4.6.1. Company overview

7.4.6.2. Financial performance

7.4.6.3. Technology Type benchmarking

7.4.6.4. Strategic initiatives

7.4.7. ICON plc

7.4.7.1. Company overview

7.4.7.2. Financial performance

7.4.7.3. Technology Type benchmarking

7.4.7.4. Strategic initiatives

7.4.8. Syneos Health

7.4.8.1. Company overview

7.4.8.2. Financial performance

7.4.8.3. Technology Type benchmarking

7.4.8.4. Strategic initiatives

7.4.9. IBM

7.4.9.1. Company overview

7.4.9.2. Financial performance

7.4.9.3. Technology Type benchmarking

7.4.9.4. Strategic initiatives

7.4.10. Teladoc Health, Inc.

7.4.10.1. Company overview

7.4.10.2. Financial performance

7.4.10.3. Technology Type benchmarking

7.4.10.4. Strategic initiatives

7.4.11. SmarterDx

7.4.11.1. Company overview

7.4.11.2. Financial performance

7.4.11.3. Technology Type benchmarking

7.4.11.4. Strategic initiatives

7.4.12. Abridge Al, Inc.

7.4.12.1. Company overview

7.4.12.2. Financial performance

7.4.12.3. Technology Type benchmarking

7.4.12.4. Strategic initiatives

7.4.13. Suki AI, Inc.

7.4.13.1. Company overview

7.4.13.2. Financial performance

7.4.13.3. Technology Type benchmarking

7.4.13.4. Strategic initiatives

7.4.14. Movano

7.4.14.1. Company overview

7.4.14.2. Financial performance

7.4.14.3. Technology Type benchmarking

7.4.14.4. Strategic initiatives

7.4.15. Heidi

7.4.15.1. Company overview

7.4.15.2. Financial performance

7.4.15.3. Technology Type benchmarking

7.4.15.4. Strategic initiatives

7.4.16. Corti

7.4.16.1. Company overview

7.4.16.2. Financial performance

7.4.16.3. Technology Type benchmarking

7.4.16.4. Strategic initiatives

7.4.17. Tortus AI.

7.4.17.1. Company overview

7.4.17.2. Financial performance

7.4.17.3. Technology Type benchmarking

7.4.17.4. Strategic initiatives

7.4.18. Nabla Technologies

7.4.18.1. Company overview

7.4.18.2. Financial performance

7.4.18.3. Technology Type benchmarking

7.4.18.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources

Table 2 List of abbreviations

Table 3 North America AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 4 North America AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 5 U.S. AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 6 U.S. AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 7 Canada AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 8 Canada AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 9 Mexico AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 10 Mexico AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 11 Europe AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 12 Europe AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 13 UK AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 14 UK AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 15 Germany AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 16 Germany AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 17 France AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 18 France AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 19 Italy AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 20 Italy AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 21 Spain AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 22 Spain AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 23 Denmark AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 24 Denmark AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 25 Sweden AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 26 Sweden AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 27 Norway AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 28 Norway AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 29 Asia Pacific AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 30 Asia Pacific AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 31 Japan AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 32 Japan AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 33 China AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 34 China AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 35 India AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 36 India AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 37 Australia AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 38 Australia AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 39 South Korea AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 40 South Korea AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 41 Thailand AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 42 Thailand AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 43 Latin America AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 44 Latin America AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 45 Brazil AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 46 Brazil AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 47 Argentina AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 48 Argentina AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 49 MEA AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 50 MEA AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 51 South Africa AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 52 South Africa AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 53 Saudi Arabia AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 54 Saudi Arabia AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 55 UAE AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 56 UAE AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

Table 57 Kuwait AI in medical writing market estimates and forecasts by type, 2018 – 2030 (USD Million)

Table 58 Kuwait AI in medical writing market estimates and forecasts by end use, 2018 – 2030 (USD Million)

List of Figures

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 AI in Medical Writing market outlook

Fig. 9 AI in Medical Writing competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 AI in Medical Writing market driver impact

Fig. 15 AI in Medical Writing market restraint impact

Fig. 16 AI in Medical Writing market strategic initiatives analysis

Fig. 17 AI in Medical Writing market: Type analysis

Fig. 18 AI in Medical Writing market: Type outlook and key takeaways

Fig. 19 Clinical writing market estimates and forecast, 2018 – 2030

Fig. 20 Type writing market estimates and forecast, 2018 – 2030

Fig. 21 Scientific writing market estimates and forecast, 2018 – 2030

Fig. 22 Others market estimates and forecast, 2018 – 2030

Fig. 23 AI in Medical Writing market: End use movement analysis

Fig. 24 AI in Medical Writing market: End use outlook and key takeaways

Fig. 25 Medical device market estimates and forecast, 2018 – 2030

Fig. 26 Pharmaceutical market estimates and forecast, 2018 – 2030

Fig. 27 Biotechnology market estimates and forecast, 2018 – 2030

Fig. 28 Others market estimates and forecast, 2018 – 2030

Fig. 29 Global AI in Medical Writing market: Regional movement analysis

Fig. 30 Global AI in Medical Writing market: Regional outlook and key takeaways

Fig. 31 Global AI in Medical Writing market share and leading players

Fig. 32 North America market share and leading players

Fig. 33 Europe market share and leading players

Fig. 34 Asia Pacific market share and leading players

Fig. 35 Latin America market share and leading players

Fig. 36 Middle East & Africa market share and leading players

Fig. 37 North America: SWOT

Fig. 38 Europe SWOT

Fig. 39 Asia Pacific SWOT

Fig. 40 Latin America SWOT

Fig. 41 MEA SWOT

Fig. 42 North America market estimates and forecasts, 2018 – 2030

Fig. 43 U.S. market estimates and forecasts, 2018 – 2030

Fig. 44 Canada market estimates and forecasts, 2018 – 2030

Fig. 45 Mexico market estimates and forecasts, 2018 – 2030

Fig. 46 Europe market estimates and forecasts, 2018 – 2030

Fig. 47 UK market estimates and forecasts, 2018 – 2030

Fig. 48 Germany market estimates and forecasts, 2018 – 2030

Fig. 49 France market estimates and forecasts, 2018 – 2030

Fig. 50 Italy market estimates and forecasts, 2018 – 2030

Fig. 51 Spain market estimates and forecasts, 2018 – 2030

Fig. 52 Denmark market estimates and forecasts, 2018 – 2030

Fig. 53 Sweden market estimates and forecasts, 2018 – 2030

Fig. 54 Norway market estimates and forecasts, 2018 – 2030

Fig. 55 Asia Pacific market estimates and forecasts, 2018 – 2030

Fig. 56 China market estimates and forecasts, 2018 – 2030

Fig. 57 Japan market estimates and forecasts, 2018 – 2030

Fig. 58 India market estimates and forecasts, 2018 – 2030

Fig. 59 Thailand market estimates and forecasts, 2018 – 2030

Fig. 60 South Korea market estimates and forecasts, 2018 – 2030

Fig. 61 Australia market estimates and forecasts, 2018 – 2030

Fig. 62 Latin America market estimates and forecasts, 2018 – 2030

Fig. 63 Brazil market estimates and forecasts, 2018 – 2030

Fig. 64 Argentina market estimates and forecasts, 2018 – 2030

Fig. 65 Middle East and Africa market estimates and forecasts, 2018 – 2030

Fig. 66 South Africa market estimates and forecasts, 2018 – 2030

Fig. 67 Saudi Arabia market estimates and forecasts, 2018 – 2030

Fig. 68 UAE market estimates and forecasts, 2018 – 2030

Fig. 69 Kuwait market estimates and forecasts, 2018 – 2030

Fig. 70 Market share of key market players- AI in Medical Writing market

Fig. 71 Key Company Categorization

Fig. 72 Company Market Share/Position Analysis, 2024

Fig. 73 Strategic Framework

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• サイダー市場規模、成長と動向分析レポート 2025-2030年
• コネクテッドリビングルーム市場規模、成長と動向分析レポート 2025-2030年
• スマートスポーツ用品市場規模、成長と動向分析レポート 2025-2030年
• 外科用ロボット市場規模、成長と動向分析レポート 2025-2030年
• 家電製品向けプラスチック市場規模、成長と動向分析レポート 2025-2030年

出版レポート一覧